Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02848651
Title A Study of Atezolizumab (MPDL3280A) as First-line Monotherapy for Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC): Clinical Evaluation of Novel Blood-Based Diagnostics [B-F1RST]
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Genentech, Inc.
Indications

lung non-small cell carcinoma

Therapies

Atezolizumab

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST